Sign in

CIK 0001396814 · Large accelerated filer

Pacira BioSciences, Inc.

Sign in to watch
Ticker
PCRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
510619477
Phone
650-242-8052
Business address
2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE, CA, 94005
Former names
Pacira Pharmaceuticals, Inc., PACIRA INC, Blue Acquisition Corp
  1. 4 Planned sale Senior Vice President, Finance sold 6,366 shares at an average $38.42 ($244,606)
  2. 4 Grant or award Chief Financial Officer acquired 9,000 shares (grant or award)
  3. 4 Grant or award Director acquired 1,775 shares (grant or award)
  4. 4 Grant or award Director acquired 1,775 shares (grant or award)
  5. 4 Grant or award Director acquired 1,775 shares (grant or award)
  6. 4 Grant or award Chief Operating Officer acquired 10,000 shares (grant or award)
  7. 4 Grant or award Director acquired 1,775 shares (grant or award)
  8. 4 Grant or award Director acquired 1,775 shares (grant or award)
  9. 4 Grant or award Director acquired 1,775 shares (grant or award)
  10. 4 Planned sale Director sold 15,000 shares at $37.04 ($555,600)
  11. 4 Open-market sale Chief Medical Officer sold 3,636 shares at an average $38.42 ($139,680)
  12. 4 Open-market sale Chief Administrative Officer sold 2,658 shares at an average $38.42 ($102,110)
  13. 4 Open-market sale CEO and Chairman sold 10,384 shares at an average $38.41 ($398,885)
  14. 4 Open-market sale Chief Clinical Officer sold 961 shares at an average $38.42 ($36,919)
  15. 4 Open-market sale Senior Vice President, Finance sold 1,207 shares at an average $38.42 ($46,369)
  16. 4 Open-market sale Chief Financial Officer sold 2,607 shares at an average $38.40 ($100,106)
  17. 4 Open-market sale President, Rest of World sold 2,153 shares at an average $38.42 ($82,710)
  18. 4 Planned sale Chief Lgl & Compliance Officer sold 6,788 shares at an average $38.46 ($261,059)
  19. 4 Open-market sale Chief Customer Officer sold 2,071 shares at an average $38.42 ($79,560)
  20. 4 Open-market sale Director sold 580 shares at $38.34 ($22,237)

Page 7 of 35 · 695 filings